[go: up one dir, main page]

AU7394294A - Macrophage migration inhibitory factor-3 - Google Patents

Macrophage migration inhibitory factor-3

Info

Publication number
AU7394294A
AU7394294A AU73942/94A AU7394294A AU7394294A AU 7394294 A AU7394294 A AU 7394294A AU 73942/94 A AU73942/94 A AU 73942/94A AU 7394294 A AU7394294 A AU 7394294A AU 7394294 A AU7394294 A AU 7394294A
Authority
AU
Australia
Prior art keywords
inhibitory factor
macrophage migration
migration inhibitory
macrophage
factor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU73942/94A
Inventor
Lisa M Fitzgerald
Haodong Li
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Human Genome Sciences Inc
Original Assignee
Human Genome Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Human Genome Sciences Inc filed Critical Human Genome Sciences Inc
Publication of AU7394294A publication Critical patent/AU7394294A/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU73942/94A 1994-05-16 1994-05-16 Macrophage migration inhibitory factor-3 Abandoned AU7394294A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1994/005385 WO1995031468A1 (en) 1994-05-16 1994-05-16 Macrophage migration inhibitory factor-3

Publications (1)

Publication Number Publication Date
AU7394294A true AU7394294A (en) 1995-12-05

Family

ID=22242566

Family Applications (1)

Application Number Title Priority Date Filing Date
AU73942/94A Abandoned AU7394294A (en) 1994-05-16 1994-05-16 Macrophage migration inhibitory factor-3

Country Status (4)

Country Link
EP (1) EP0770086A4 (en)
JP (1) JPH10500301A (en)
AU (1) AU7394294A (en)
WO (1) WO1995031468A1 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6458349B1 (en) 1995-06-02 2002-10-01 Human Genome Sciences, Inc. Chemokine β-4 polypeptides
US6174995B1 (en) 1994-08-23 2001-01-16 Haodong Li Human chemokines, CKβ4 and CKβ10/MCP-4
US6391589B1 (en) 1994-08-23 2002-05-21 Human Genome Sciences, Inc. Human chemokine beta-10 mutant polypeptides
US6290948B1 (en) * 1996-05-14 2001-09-18 Smithkline Beecham Corporation Method of treating sepsis and ARDS using chamohine beta-10
US6812327B1 (en) 1996-10-25 2004-11-02 Human Genome Sciences, Inc. Neutrokine-alpha polypeptides
US8212004B2 (en) 1999-03-02 2012-07-03 Human Genome Sciences, Inc. Neutrokine-alpha fusion proteins
KR20060088905A (en) 2000-06-16 2006-08-07 휴먼 게놈 사이언시즈, 인코포레이티드 Antibodies that immunospecifically bind to LYXs
US7879328B2 (en) 2000-06-16 2011-02-01 Human Genome Sciences, Inc. Antibodies that immunospecifically bind to B lymphocyte stimulator
AU2001288301A1 (en) 2000-08-18 2002-03-04 Human Genome Sciences, Inc. Binding polypeptides and methods based thereon
WO2002020758A2 (en) * 2000-09-05 2002-03-14 Curagen Corporation Novel proteins and nucleic acids encoding same
EP1534752B1 (en) 2002-05-01 2011-08-03 Human Genome Sciences, Inc. Antibodies that specifically bind to chemokine beta-4
US9168286B2 (en) 2005-10-13 2015-10-27 Human Genome Sciences, Inc. Methods and compositions for use in treatment of patients with autoantibody positive disease
US8211649B2 (en) 2006-03-31 2012-07-03 Human Genome Sciences, Inc. Methods of diagnosing and prognosing hodgkin's lymphoma
KR101919170B1 (en) 2010-11-19 2018-11-15 에자이 알앤드디 매니지먼트 가부시키가이샤 Neutralizing anti-ccl20 antibodies
US9958456B2 (en) 2011-10-07 2018-05-01 Baxalta Incorporated OxMIF as a diagnostic marker
WO2013184209A1 (en) * 2012-06-04 2013-12-12 Ludwig Institute For Cancer Research Ltd. Mif for use in methods of treating subjects with a neurodegenerative disorder

Also Published As

Publication number Publication date
EP0770086A4 (en) 1998-07-15
WO1995031468A1 (en) 1995-11-23
JPH10500301A (en) 1998-01-13
EP0770086A1 (en) 1997-05-02

Similar Documents

Publication Publication Date Title
AU6603396A (en) Attachment strips
AU3304795A (en) Bisresorcinyltriazines
AU3304995A (en) 2-Hydroxyphenyltriazines
AU2837895A (en) Thiazine- or thiazepine-derivatives
AU7394294A (en) Macrophage migration inhibitory factor-3
AU4044795A (en) Handleset
AU4131596A (en) Polyglycomers
AU2844595A (en) Substituted biphenyloxazolines
AU2308295A (en) Heterocyclylbenzonitriles
AU1963395A (en) Boom-structure
AU2634695A (en) Hull-related arrangement
AU4029295A (en) Thienopyridones
AU7469594A (en) Poop-scoop
AU3166195A (en) Acylimidazopyridines
AU4590996A (en) Boekomslag
AU1603595A (en) Meso-azanoradamantanes
AU3166095A (en) Benzylimidazopyridines
AU2411395A (en) Hydrocopter
AU693187B2 (en) Engaging element
AU693176C (en) Campervan
AU661263B3 (en) Rotakite
AU658811B3 (en) Bum-bag
AUPM429094A0 (en) Holophotal array
AUPN023194A0 (en) Ladder rack
AUPN024794A0 (en) Improved cooking system